Fatal Peripartum Cardiomyopathy after Bupivacaine Local Injection in Elective Cesarean Section: A Case Report
Journal of the Korean Society of Emergency Medicine
;
: 214-218, 2016.
Article
in English
| WPRIM
| ID: wpr-160726
ABSTRACT
Bupivacaine is frequently used for pain control and local anesthesia. However, it is associated with certain acute and fatal side effects, although rare, including cardiac and central nervous system toxicities. In particular, bupivacaine-induced cardiac toxicity may be fatal. This condition can be diagnosed as bupivacaine-induced cardiotoxicity by excluding other causes and determining a history of bupivacaine administration. However, in emergency situations, recognizing bupivacaine toxicity can be difficult due to the physician's lack of awareness regarding the condition or in the absence of clear communication regarding the patient's medical history. In the current case report, we describe our experience with strong suspected bupivacaine-induced cardiotoxicity in a patient who underwent cesarean section along with a review of the literature.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Bupivacaine
/
Central Nervous System
/
Cesarean Section
/
Emergencies
/
Peripartum Period
/
Cardiotoxicity
/
Anesthesia, Local
/
Cardiomyopathies
Type of study:
Diagnostic study
Limits:
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
Journal of the Korean Society of Emergency Medicine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS